Antony Adamson

Dr Antony Adamson is a Principal Experimental Officer at the University of Manchester's Faculty of Biology, Medicine and Health (FBMH), within the Platform Sciences department. His work focuses on molecular mechanisms in circadian rhythms, gene editing (CRISPR-Cas9), stem cell biology, and inflammatory pathways. He has contributed to projects such as the Oxford Nanopore PromethION initiative and research on epigenetic mechanisms in blood pressure regulation.

His research interests include circadian clock dynamics, development of mouse models for genetic studies, and understanding inflammatory responses through multi-omics approaches. Projects under his involvement explore CRISPR integration into organic electronics for genotyping and genome-wide methylation analysis in kidney disease.

Dr Adamson's publications highlight advancements in CRISPR technologies, circadian biology, and immune system regulation. He has collaborated on datasets involving NF-κB signaling and cardiac progenitor cell specification. Media contributions include expert commentary on CRISPR controversies and radio discussions on gene editing.

He leads or co-leads three active/funded projects and has supervised research work. His contributions span experimental design, genetic engineering, and interdisciplinary collaborations, advancing translational research in health and disease.